ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0296

Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome

Laura Mas Sánchez1, JOSE ELOY OLLER RODRIGUEZ2, Elena Grau García3, Carmen Riesco Barcena4, SAMUEL LEAL5, Marta de la Rubia navarro6, Anderson Huaylla Quispe7, Pablo Muñoz Martínez8, Alba Torrat noves9, Daniel Ramos Castro10, Iago Alcantara Alvarez11, Belén Villanueva Mañés11, Miguel Simeo Vinaixa12, Andrés Pérez Hurtado13 and Jose A Román-Ivorra14, 1Resident at Hospital Universitari i Politecnic La Fe, Valéncia, Spain, 2HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE, VALENCIA, Spain, 3HUP La Fe, Valencia, Spain, 4Hospital Universitario i Politecnic La Fe (Valencia-Spain), Valéncia, Spain, 5Hospital La Fe, Valencia, Spain, 6Rheumatology department, Hospital La Fe, Valéncia, Spain, 7Medicina, Valéncia, Spain, 8Hospital Universitario y Politècnico La Fe, Sagunto, Spain, 9Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Comunidad Valenciana, Spain, 10Hospital Universitario y Politècnico La Fe, Valencia, Spain, 11Rheumatology Department. HUP La Fe, Valencia, Comunidad Valenciana, Spain, 12Hospital Universitari i Politecnic La Fe, Valencia, Spain, 13Rheumatology Department. HUP La Fe, Valencia, Spain, 14Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain

Meeting: ACR Convergence 2024

Keywords: cartilage, Collagen-Induced Arthritis, Eye Disorders, Heart disease, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: There is limited information about musculoskeletal involvement in Marfan syndrome (MS), especially concerning bone metabolism.

Methods: We conducted a retrospective and descriptive study of patients diagnosed with Marfan Syndrome (according to Ghent Criteria) followed in Rheumatology since 2012, collecting demographic, clinical, analytical, and densitometric data.

Results: A total of 65 patients were included (52.3% women) with a mean age of 39 (16) years. Genetically confirmed diagnosis was present in 48 cases, with 3 of them as index cases, and the FBN1 gene was the most frequently affected (93.8%).

Eighty percent of patients had musculoskeletal involvement (see Table 1), with a history of fractures in 4.6% of patients. About 40% of the performed densitometries showed values in the Osteoporosis range. We observed a tendency for patients with decreased densitometry values to have a higher proportion of aortic dilation (P=0.053) and thoracic wall involvement (P=0.059). Elevated levels of autoantibodies were found in 11 patients.

Furthermore, a statistically significant association was observed between the presence of aortic dilation and abnormalities of the thoracic wall (P=0.027) and the presence of cardiopathy (P< 0.001). There was also a tendency to have greater demineralization of the lumbar spine in patients with cardiopathy, aortic dilation, and thoracic wall abnormalities, with the latter being more frequently observed in male patients.

Conclusion: Up to 80% of MS patients presented musculoskeletal manifestations, and 40% showed densitometry values in the osteoporosis range. An association was observed between findings of thoracic wall deformities and the presence of aortic dilation. There was also a tendency to have greater demineralization of the lumbar spine in patients with aortic dilation and thoracic wall abnormalities.

Supporting image 1

Table 1. Clinical manifestations in Marfan Syndrome.


Disclosures: L. Mas Sánchez: None; J. OLLER RODRIGUEZ: None; E. Grau García: None; C. Riesco Barcena: None; S. LEAL: None; M. de la Rubia navarro: None; A. Huaylla Quispe: None; P. Muñoz Martínez: None; A. Torrat noves: None; D. Ramos Castro: None; I. Alcantara Alvarez: None; B. Villanueva Mañés: None; M. Simeo Vinaixa: None; A. Pérez Hurtado: None; J. Román-Ivorra: None.

To cite this abstract in AMA style:

Mas Sánchez L, OLLER RODRIGUEZ J, Grau García E, Riesco Barcena C, LEAL S, de la Rubia navarro M, Huaylla Quispe A, Muñoz Martínez P, Torrat noves A, Ramos Castro D, Alcantara Alvarez I, Villanueva Mañés B, Simeo Vinaixa M, Pérez Hurtado A, Román-Ivorra J. Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/musculoskeletal-manifestations-in-patients-diagnosed-with-marfan-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-manifestations-in-patients-diagnosed-with-marfan-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology